Fragile X syndrome is associated with a trinucleotide (CGG) repeat expansion in the 5′-untranslated region of the FMR1 gene and hypermethylation of the FMR1 promoter. Rare cases of clinically normal males (HFM) have been identified with an expanded CGG repeat; however, here, the FMR1 promoter is not methylated. Using classical complementation (cell fusion) studies, we analyzed if possible differences in the genetic background between HFM and cells from individuals with fragile X syndrome (FX cells) could have an influence on the methylation status of the FMR1 promoter. We observed that demethylation of the hypermethylated FMR1 promoter can occur when FX cells are complemented (by cell fusion) with cells from HFM as well as with cells from control individuals. The observed demethylation is specific and can happen without DNA replication. In contrast, demethylation was not observed when cells from unrelated individuals with fragile X syndrome were fused, indicating that FX cells have lost the necessary factor(s) to demethylate the aberrantly methylated FMR1 promoter.
the DNA replication (12, 13) . Apparently, the threshold for the methylation machinery to be attracted to the site depends on the length of the repeat; however, in some occasions cells can "escape" from this aberrant methylation of the FMR1 promoter.
We were intrigued by the observation that the FMR1 promoter in cells from individuals with fragile X syndrome (FX cells) is methylated whereas the FMR1 promoter of HFM is unmethylated. To determine if possible differences in the genetic background of FX cells and cells from HFM might influence the methylation status of the FMR1 promoter, we have set up a series of somatic cell fusion experiments. With these classical complementation studies, we observed that in heterokaryons the hypermethylated promoter of the FMR1 gene of FX cells is in a reversible state and that factor(s) necessary for its demethylation are present in fibroblasts from HFM as well as in control cells.
MATERIALS AND METHODS

Somatic cell hybridization and sorting
Primary human fibroblasts were cultured in Ham's F10 medium, supplemented with 10% fetal calf serum (FCS) and Penicillin/Streptomycin (P/S), in 5% CO 2 at 37°C. Before cell fusion (2 days), the individual cell lines (Table 1) were labeled with fluorescent beads (Polysciences, Inc.Warrington, PA). The FX fibroblast lines were labeled with Fluoresbrite PC Red microspheres (diameter 1.0 µm), while the control cell lines and the HFM cell line were labeled with green Fluoresbrite Carboxylate microspheres (diameter 1.0 µm). We followed a previously described procedure (14) , with some adaptations, that is, overnight (O/N) incubation of the fibroblasts in a Ham's F10 medium with fluorescent beads and 2% FCS. The uptake and distribution of the beads was controlled using Zeiss Axioplan 2 (Carl Zeiss, New York, NY). The cells were seeded on cover slips in 24-well plates, fixed with 4% paraformaldehyde for 7 min at RT, and briefly washed with water. The nuclei were counterstained with 20x DAPI in Vectashield mounting medium. After O/N incubation with the fluorescent beads, the fibroblast cultures were trypsinized, and the cells were counted. Equal amounts of two cell lines were mixed in one flask and cocultivated O/N. Cell fusions were performed following a modification of the procedure described previously (15) . The cells were washed twice with Ham's F10 medium without additives. Then the cell fusion was carried out as follows: 1 ml of 50% PEG/10% DMSO solution was added to every T75 flask, and the mixture was rocked for 2 min. Then, 1 ml of 25% PEG solution was added, and the flask was rocked again for 2 min. Then, 8 ml of Ham's F10 medium were added twice. Finally, the whole mixture was discarded, and the fibroblasts were rinsed twice with 8 ml of Ham's F10 medium. The medium was removed and replaced by 10 ml of Ham's F10 medium with supplements, and the fibroblasts were cultured as described above. Twenty-four hours after somatic cell hybridization, the cultures were harvested and the fibroblasts were resuspended to a concentration of 10 6 cells/ml in PBS with 1% FCS. The population of heterokaryons containing both red and green fluorescent beads (area indicated as P1 in Figure 2D ) was sorted out using a FACSDiVa (Vantage) cell sorter with a purity-sorting mode.
Bisulfite treatment of DNA
Genomic DNA from the sorted heterokaryons or from the individual cell lines was extracted following the protocol of the DNA Isolation Kits, Gentra Systems, Inc. (Minneapolis, MN). The bisulfite conversion of DNA was carried out following the protocol originally developed by Frommer et al. (16) , with some recent modifications (17) . Approximately 1.5 µg DNA was used from each sample. NaOH was added to a final concentration of 0.3 M, and the samples (final reaction volume 55.5 µl) were incubated at 37°C for 30 min in a water bath. The samples were then denatured at 95°C for 3 min in a water bath and placed on ice water. 500 µl freshly prepared sodium bisulfite/hydroquinone solution with a final concentration of 2.8 M and 2.5 mM, respectively, were added to the samples. The samples were overlaid with mineral oil and incubated at 55°C for 16 h in a water bath at dark. Subsequently the samples were desalted with the Wizard DNA cleanup kit (Promega) and desulfonated by addition of NaOH to a final concentration of 0.3 M and incubation at 37°C for 15 min. The samples were neutralized by addition of ammonium acetate (pH 7.0) to a final concentration of 3 M, and DNA was precipitated with 4 volumes of absolute ethanol, dried, and resuspended in 1 mM TRIS/HCl pH 8.0. Aliquots of the samples were used later as PCR templates.
PCR, cloning, and sequencing of bisulfite-treated DNA
Two subsequent PCR reactions were performed, the second, semi-nested. The bisulfite-treated DNA was PCR amplified in a 50 µl volume reaction, containing reaction buffer, 1 mM MgCl 2 , 10% DMSO, 0.2 µM of each dNTP, 0.4 µM of the forward and reverse primer, 4 U of Platinum Taq polymerase (Invitrogen, Carlsbad, CA). In the first PCR reaction, we used equal amounts of two forward primers -1F 5′ GGA ATT TTA GAG AGG TTG AAT TGG G 3′ and 1F met 5′ GGA ATT TTA GAG AGG TCG AAT TGG G 3′ (11, 18) and to determine the 52 potentially methylated CpGs (as described by Pietrobono and colleagues (11)), we used the reverse primer 5aR 5′ CAC ACC CCC TAA CAAC 3′. Although this primer will match with the unmethylated C at position 4, no bias has been found in the amplification when analyzing a methylated or an unmethylated FMR1 promoter region (personal communication Pietrobono et al.), which we confirmed (Fig. 1E) . The second semi-nested PCR was with the same reverse primer and an internal forward primer 2F 5′ GTT ATT GAG TGT ATT TTT GTA GAA ATG GG 3′. Cycling conditions for both PCR reactions were initial denaturation at 95°C for 5 min followed by 30 cycles at 95°C for 30 s, 55°C for 30 s, and 72°C for 1 min and a final elongation step at 74°C for 10 min. Since the second semi-nested PCR is extremely sensitive, DNA-negative controls were always processed along with the samples as a control for possible contamination or nonspecific PCR.
The PCR products from the semi-nested PCR were separated on a 2% agarose gel and the PCR fragment was cut out of the gel and purified using the QIAquick Gel Extraction kit (Qiagen). The purified fragments were cloned into the pcDNA3.1/V5-His TOPO TA vector (Invitrogen) and 2 µl of the reaction were used for transformation of competent Escherichia coli (Top10 cells) according to the manufacturer's protocols (pcDNA3.1/V5-His TOPO TA Expression Kit, Invitrogen). Colonies containing the insert were identified by colony PCR with the following conditions: 1.5 mM MgCl 2, 0.2 µM of each dNTP, 0.4 µM of the T7 and BGH primer, reaction buffer, 0.5 U of Platinum Taq polymerase (Invitrogen) in a reaction volume of 10 µl. Miniprep DNA from the positive clones was extracted after overnight growth, and the plasmid DNA was used for sequencing. Every clone was sequenced in both directions by using the T7 and BGH primers mapping in the vector.
One µg of the plasmid DNA was used as a template for the sequencing reactions, which were in 10 µl reaction volume, 2 µl BDT mix, 2 µl 5× buffer, 0.2 µM sequencing primer (ABI Prism BigDye Terminator Cycle Sequencing Ready Reactions Kit, Applied Biosystems, Foster City, CA). The cycle sequencing consisted of initial denaturation at 96°C for 45 s, followed by 30 cycles at 96°C for 10 s, 51°C for 5 s, and 60°C for 4 min. The sequence reactions were run on an ABI Prism 377 Sequencer and analyzed with the ABI Prism Collection software.
Methylation sensitive PCR for the SNRPN gene
For the detection of the methylated and unmethylated copy of the small nuclear ribonucleoprotein-associated polypeptide N (SNRPN) gene, we applied the methylation-specific PCR. The DNA was treated with sodium bisulfite as described above. The PCR conditions were performed following the descriptions in Kubota et al. (19) .
Southern blot analysis
Genomic DNA was digested with 50 units of HindIII and EagI in a volume of 50 µl, containing 5 µl 10× SuRE/Cut Buffer H, and 3 µl 50 mM spermidine O/N at 37°C. The samples were run on a 0.7% agarose gel in TBE buffer for 20 h at 45 V. The gel was treated for 15 min in 0.25 M HCl, 30 min in denaturation buffer and 2 × 15 min in neutralization buffer. After O/N blotting in 20 × SSC to a nylon filter (Boehringer Mannheim, Rot Kreuz, Switzerland), the DNA was fixed to the filter by baking the membrane for 15−30 min at 120°C. Prehybridization and hybridization were performed in DIG Easy Hyb solution (Roche, Cat. no. 1 603 558) for 1 and 18 h, respectively at 42°C. As a probe, we used nonradioactive DIG-labeled pP2 DNA probe. The filter was washed 2 × 5 min with 50 ml 2×SSC/0.1%SDS at room temperature, followed by 2 × 15 min in 1× SSC/0.1%SDS at 65°C. After incubation for 60 min in 1 × blocking solution, the membrane was incubated for 30 min with anti-digoxigenine-AP-conjugate (Roche). The final detection was performed with CDP star solution (Roche) with 1 × detection buffer followed by autoradiography.
DNA replication
Fibroblasts were cultured in 6 well plates with covers slips inside. The confluent monolayers were fused following the procedure described above. Two hours after cell fusion the culture was incubated for the next 24 h with medium containing 10 µCi methyl-3 H thymidine (20) . The proportion of S phase in the culture was determined in five independent experiments. The total number of nuclei in the heterokaryons was counted, then only the nuclei in S phase, and finally, the percentage was calculated. The data from these experiments are presented in Table 2 .
RESULTS
Characterization of the cell lines
Primary fibroblast cell strains from males with fragile X syndrome, from a HFM male and from normal males were analyzed for the length of the CGG repeat, the methylation status of the FMR1 promoter, FMR1 transcription, and FMRP expression. The approximate size of the CGG repeat and the methylation status of the FMR1 promoter in the different FX cell lines were determined by Southern blot analysis. The exact methylation status of 52 CpG sites in the FMR1 promoter region (11, 18) was defined by bisulfite genomic sequencing (17) of a number of clones from every cell line before co-cultivation and cell fusion. FMR1 transcription and translation were analyzed by RT-PCR and Western blotting, respectively. The characteristics of the cell lines are presented in Table 1 
Complementation studies FX and HFM cells
To test if differences in the cellular background might play a role on the (de)methylation of the FMR1 promoter in FX cells, we performed some cell fusion experiments. FX fibroblasts (FX1 and FX2) were labeled with red fluorescent beads, and then cocultivated with HFM fibroblasts, labeled with green fluorescent beads ( Fig. 2A) . After cell fusion, a mixed cell population was obtained (Fig. 2B) . To isolate only the heterokaryons resulting from fusion between the two parental cell lines, cell hybrids containing both red and green fluorescent beads (Fig. 2C) were selected by flow cytometry. The heterokaryons from the area P1 were sorted out (Fig. 2D) .
The DNA methylation pattern of the FMR1 promoter was examined by bisulfite genomic sequencing. First the DNA extracted from the sorted heterokaryons was modified by treatment with sodium bisulfite. Then the region of the FMR1 promoter was PCR amplified. The PCR product was cloned in a plasmid vector, and eventually several individual clones were sequenced. Figure 1C shows the results from fusions of FX1 and FX2 cells with HFM cells. Surprisingly, all 34 clones analyzed were found almost completely unmethylated. In a number of clones a few CpG sites were still methylated. As the promoter region of HFM is completely unmethylated (data not shown) we conclude that these clones derived from the originally methylated promoter in the FX cells. In several independent experiments with different combinations between FX cells and the HFM cell line, we found only a demethylated promoter, suggesting that within the 24 h, after somatic cell hybridization the FMR1 promoter region in the FX cells changed to a demethylated status.
Complementation studies FX and control cells
In addition, we performed a number of independent fusion experiments between FX cells and control cells. The promoter region of the control cell lines was completely free of methylation (data not shown). When FX cells (FX1) were fused with control cells (C1) again, only demethylated sequences of the FMR1 promoter were identified. From the 14 clones sequenced, 11 were completely free of methylation and in three clones we found only one cytosine still methylated (Fig. 1D, upper panel) . The same approach was used with the two other FX cell lines (FX2 and FX3). FX2 was fused with C1 as well as with C2, and FX3 was fused with C2. From the 19 clones analyzed, again 16 clones were found completely free of methylation and 3 clones with only single cytosines still methylated (Fig. 1D, lower panel) . These results indicate that the hypermethylated FMR1 promoter in FX cells can be demethylated after fusion with control cells as well, and therefore the HFM cells do not have additional factors contributing to the demethylation of the FMR1 promoter.
Southern analysis of cell fusion between FX and control cells
In addition we used Southern hybridization to analyze the DNA from a complementation experiment of FX1 and C1 cells. Because the yield of DNA obtained after labeling, cell fusion and sorting were very low, for the Southern hybridization experiments, we fused FX1 with C1 cells and extracted DNA from the total cell population (without cell sorting). We used HindIII and a methylation sensitive restriction enzyme (EagI) to determine the length of the CGG repeat and the methylation status of CpGs 16 and 17 in the FMR1 promoter (Fig. 1A) . The methylated allele with normal CGG repeat (in females) is digested only by HindIII and detected on a Southern blot as a 5.2 kb band (data not shown). In Fig. 2E The DNA from the heterokaryons contains DNA from the two parental cell lines
We controlled whether these heterokaryons contained the nuclei of the two parental cell lines by using highly polymorphic DNA markers. DNA of the sorted cells was compared with that of the parental cell lines. The analysis of autosomal markers D3S1358, vWA, D8S1179, and D18S51 is shown in Fig. 3A . For markers D3S1358 and vWA four alleles are detected, two coming from each cell line; for D8S1179 three alleles were found, since allele 146.28 is common for the two cell lines; for D18S51 three alleles were found, since allele 304.99 is common for the two cell lines. These results show that in the sorted heterokaryons the DNA profiles of the two starting cell lines are present.
Although chromosomal loss in heterokaryons (multinuclear) of human cells is rare, we analyzed the sorted heterokaryons for the presence of the X chromosomes belonging to the two parental cell lines. In Fig. 3B the results from the analysis of marker DXS1068 are presented. As shown in the lower part of the panel the alleles of the two parental cell lines were found in the DNA from sorted heterokaryons, indicating that both X chromosomes (from FX1 and C1) were present in the fused cells.
Specificity of the cell sorting and bisulfite sequencing methods
To test the specificity of the cell sorting, we analyzed also the DNA from the cells in area P2 containing only red fluorescent beads (Fig. 2D) . In those samples, we could find only clones where the FMR1 promoter was methylated (data not shown), which confirms that the red labeled cells are single FX cells or fused with each other. In addition, it shows that procedures like labeling, fusion, and sorting are not responsible for the observed changes from a methylated to a demethylated status of the FMR1 promoter. The findings of only methylated clones from the three FX cell lines (Fig. 1B) and unmethylated clones from the control and HFM lines, as well as the fact that in the DNA from the FX cells, the cytosines (C) not belonging to a CpG were always converted to uracils (U), confirmed the specificity of the bisulfite treatment.
Control for cloning and PCR bias
To exclude the possibility that our findings were due to a PCR and/or cloning bias after bisulfite treatment (17, 21), we mixed genomic DNA from FX1 (containing methylated FMR1 promoter) and genomic DNA from C1 (containing not methylated FMR1 promoter) in ratios 20:80, 50:50 and 80:20, respectively, and subjected the samples to the same procedure. We obtained the expected number of clones with and without methylation, which confirms that no bias is introduced. The results from the analysis of the 50:50 mix are shown in Fig. 1E .
FX cells cannot complement each other
As described above and illustrated in Fig. 1F , the fusion procedure itself is not influencing the methylated status of the FMR1 gene. When FX cell lines were fused with themselves, only methylated copies of the promoter were found (Fig. 1F, upper and middle panel) . In addition, when cells from unrelated individuals with fragile X syndrome were fused with each other, again only methylated clones were detected. These results indicate that the FX cells (with a different genetic background) cannot complement each other (Fig. 1F, lower panel) .
Specificity of the demethylation
We showed that in three different FX cell lines the FMR1 promoter could be demethylated. Next, we examined whether the demethylation found after cell fusion was affecting also other sequences in the genome, which are normally maintained in a methylated state. As an example we analyzed the Prader-Willie/Angelman syndrome (PWS/AS) critical region on chromosome region 15q11-q13, which is known to contain several sites where one allele is methylated and inactive, while the other is unmethylated and active (19) . The CpG island of the SNRPN gene, is almost completely methylated on the maternal and unmethylated on the paternal chromosome. By methylation-sensitive PCR, we analyzed in parallel the DNA from the individual cell lines and from the corresponding sorted heterokaryons (19) . In these experiments both the methylated and unmethylated copies were found in all samples (Fig. 4) . Since the cell fusion did not change the methylation status of the SNRPN CpG island, there is no evidence for a general effect on the methylation status of the genome, and therefore, the observed demethylation of the FMR1 promoter seems specific.
Demethylation without DNA replication
We observed demethylation of the FMR1 promoter in FX cells within a relatively short time frame (24 h after cell fusion). Therefore, we tested if this demethylation event was occurring with or without replication of the DNA. Cell cultures after fusion were incubated with methyl -3 H thymidine for a period of 24 h, and the presence of newly synthesized DNA in the nuclei of the heterokaryons was analyzed (Fig. 5) . The results from counting the nuclei and S phases indicate that only in a limited fraction (13 to 17%) of the nuclei in the heterokaryons DNA replication has occurred, while in most of the nuclei in the fused cells, the DNA did not replicate in this time frame (Table 2 ). We therefore assume that in the DNA extracted from the heterokaryons after sorting, a similar proportion (under 20%) would represent newly replicated DNA, and the remaining (more than 80%) of the DNA was already present in the nuclei of the cells before the fusion. The fact that we found only unmethylated copies of the FMR1 promoter suggests that, under our experimental conditions, for the observed demethylation, DNA replication is not necessary.
DISCUSSION
In general, when the CGG repeat in the FMR1 gene exceeds more than 200 units, hypermethylation of the repeat and the upstream promoter occurs, resulting in transcriptional silencing of the gene. However, as an exception in HFM individuals, despite the FMR1 full mutation repeat expansion (>200 units), the promoter seems to "escape" this aberrant methylation. In our current work, we have analyzed if differences in the genetic background of FX cells vs. HFM or control cells can influence the methylation status of the FMR1 promoter. After cell fusion, we observed a reproducible change from a hypermethylated into a nonmethylated FMR1 promoter. The observation that fibroblasts from normal individuals are able to demethylate the FMR1 promoter as effectively as the HFM cells suggests that for the observed demethylation no additional factors are present in the HFM compared with control cells. However, when different FX fibroblasts were fused, no demethylation was observed in the heterokaryons, indicating that FX cells are missing the necessary factor(s) for the demethylation of the FMR1 gene.
Demethylation is one of the principle epigenetic events that play a role for the fine tuning of gene expression in cells (22, 23) . Several mechanisms for demethylation operating at different points in development and in different cell types have been described. The passive mechanism implicates that demethylation of Me -CpG could result from the absence of maintenance methylation after replication (24) . This mechanism would require several DNA replication cycles before a significant part of the daughter molecules are effectively demethylated. Because in our experiments, only a small proportion of the nuclei after fusion reached S phase, while we observe complete demethylation of the FMR1 promoter, the abovementioned passive mechanism is not likely. Therefore, the findings in this paper imply an active demethylation. Several models for active demethylation have been postulated. The first model involves a demethylase activity, which removes the methyl groups without altering the phosphodiester backbone of the target DNA (25) (26) (27) . Another model suggests the excision of the Me -cytosine with subsequent processing of the a-basic site by DNA repair enzymes (28) . A third study describes a demethylation mechanism by excision of the dinucleotide Me -CpG (29) .
A few examples for gene specific active demethylation are available. The promoter enhancer of the interleukin-2 gene is demethylated within 20 min after activation of T lymphocytes (30) .
Another study reports specific demethylation of the rat α-actin gene promoter by cellular extracts from L8 rat myoblasts (22, 29, 31) . In both studies, the demethylation is reported to take place without DNA replication. Similarities between these findings and our results are present. In our experiments we 'expose' the FMR1 gene to the whole cellular machinery, without depriving the methylated FMR1 promoter from the influence of possible cis and trans acting factors. The fine-tuning of gene regulation involves the simultaneous binding of activating and repressing complexes to the promoters of genes, which are transcriptional ready (32) . The balance between these complexes, competing for certain binding sites, is regulated by cellular signals (33) , and this balance could be changed after the cell fusion.
Other studies on the FMR1 promoter showed that when a human X chromosome with a methylated FMR1 allele was introduced by microcell fusion into mouse embryonic cells, the FMR1 gene could be demethylated and reactivated (34) . However, the same allele remained unchanged when introduced into immortalized rodent cells (A9). These hybrid clones were analyzed after several subsequent cell divisions, accompanied sometimes with severe chromosomal rearrangements (34) . Therefore human trans and sometimes even cis acting factors normally influencing the methylation of the FMR1 promoter could not play a role in such human−rodent hybrids. In contrast, our experimental setting is based on an entire human cell environment and studies the effect on the FMR1 promoter within a relatively short time frame (24 h) in differentiated cells and without cell division. Therefore the above-mentioned studies cannot directly be compared with the findings in our current work.
We hypothesize that by fusion of FX with HFM or control cells, we provide the FX fibroblasts with the necessary repair/demethylating factor(s), which are already operating and active in the normal cells. The analysis of changes in the methylation status of all promoters in the heterokaryons is beyond the scope of this paper. As an example, we analyzed the CpG islands of the SNRPN promoter where the maternal allele is normally methylated. We showed that similar to control cells, in FX cells, the maternal allele was methylated and that after fusion the same SNRPN allele remained methylated while the hypermethylated FMR1 promoter was changed to a demethylated status. As there is no direct evidence that after cell fusion a general demethylation occurs, the observed demethylation of the hypermethylated FMR1 promoter seems to be specific.
Because of the limitations of the cell fusion approach (presence of mRNA and FMRP from the control cells), we are not able to analyze the possible restoration of expression of the FMR1 gene in the FX cells. The finding that no demethylation of the FMR1 promoter is observed in heterokaryons of FX cells (lacking FMRP), together with the already published data concerning the role of FMRP on the regulation of expression of a large number of genes (35) , suggests that FMRP may be (in)directly involved in the demethylation/repair pathway of its own promoter.
Aberrations in the DNA methylation patterns are recognized as hallmarks in cancer. It is not clear why certain CpG islands are more prone to undergo aberrant DNA methylation and why others are spared from hypermethylation. In general, studies are performed on cells where many promoters are hypermethylated which makes the interpretation of the results even more complex. Characterization of the mechanism involved in the unique epigenetic gene silencing of the FMR1 gene may provide important clues for understanding the silencing pathway in general. 
